Solid Reversal from the Support Zone. Previous Structure was Bullish and Price was inside the Range.
Long above Level market for Targets marked with Green Dots
ALKEM looks PRIME Long , Consolidating side ways in yearly range + it has good fundamentals too.
Entry : 1750 - 1725 Range
Stoploss : 3% (Closing Basis) OR (iF adding in portfolio be a liberal)
Basic Target: 1850
if you have any queries regarding above idea or any other stock feel free to D'M
& Do Visit us : Click Here, We have curated some of the best...
Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. The Company offers various products, such as CLAVAM 375, CLAVAM BID DRY SYRUP, CLAVAM INJ 300MG, FREEAIR NASAL SPRAY, PAN 40MG INJECTION (VIAL), PAN/40MG TABLETS, PROWEL DRY SYRUP (30ML), TAXCLAV 100 DT TABLETS, SATROGYL O DRY SYRUP, XONE/500MG VAIL, MEROSURE KIT 500, MEROSURE 500 MG and ZADONASE, among others. The Company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
ALKEM
